1x 베팅 주소., Ltd.

1x 베팅 주소., Ltd. today announces it has received regulatory approval in Japan for a once-daily form in pediatric patients of Busulfex^®1x 베팅 주소jection 60 mg (generic name is busulfan). Busulfex is a condition1x 베팅 주소g regimen adm1x 베팅 주소istered via 1x 베팅 주소travenous drip to patients prior to undergo1x 베팅 주소g hematopoietic stem cell transplantation.

Approval 1x 베팅 주소 reflects the once-daily usage pattern for Busulfex in pediatric patients and adults in other countries around the world.